TENAX THERAPEUTICS INC (TENX:NASDAQ)
$14.425 -0.535 (-3.5762%)
Analysed TENAX THERAPEUTICS INC (TENX:NASDAQ) News Sources
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
17-03-2026
yahoo.com
Tenax Therapeutics: Q4 Earnings Snapshot
10-03-2026
yahoo.com
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
10-03-2026
yahoo.com
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference
03-03-2026
yahoo.com
Tenax Therapeutics Shares Phase III Levosimendan Progress, H2 Data Timeline at Guggenheim Conference
15-02-2026
marketbeat.com
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026
04-02-2026
yahoo.com
Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick
08-01-2026
yahoo.com
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
17-12-2025
yahoo.com
Tenax Therapeutics to Participate in Upcoming Investor Conferences
25-11-2025
yahoo.com
Companies Like Tenax Therapeutics (NASDAQ:TENX) Are In A Position To Invest In Growth
13-11-2025
yahoo.com
What is the current price of TENAX THERAPEUTICS INC (TENX:NASDAQ)?
The current price of TENAX THERAPEUTICS INC (TENX:NASDAQ) is $14.425.
TENAX THERAPEUTICS INC (TENX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TENAX THERAPEUTICS INC (TENX:NASDAQ) since the previous trading day is $-0.535.
TENAX THERAPEUTICS INC (TENX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TENAX THERAPEUTICS INC (TENX:NASDAQ) since the previous trading day is -3.5762%.
What is the most recent average sentiment score for TENAX THERAPEUTICS INC (TENX:NASDAQ)?
The most recent average sentiment score for TENAX THERAPEUTICS INC (TENX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for TENAX THERAPEUTICS INC (TENX:NASDAQ)?
The most recent sentiment for TENAX THERAPEUTICS INC (TENX:NASDAQ) is .
SEC-8K** Filing Available For TENAX THERAPEUTICS INC (TENX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.